A Study to Assess the Long-Term Safety and Efficacy of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Patients With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy

National Taiwan University Hospital, Taipei

Chang Gung Memorial Hospital, Taoyuan District

Hospital El Cruce, San Juan Bautista

The Cyprus Institute of Neurology and Genetics, Égkomi

Perron Institute for Neurological and Translational Science, Murdoch

The Neurological Institute of New York, New York

Taipei Veterans General Hospital, Taipei

Hôpital de la Timone, Marseille

Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) - Fondazione Istituto Neurologico Carlo Besta, Milan

Johns Hopkins University Neurology Research Office, Baltimore

Fondazione IRCCS Policlinico San Matteo, Pavia

University of North Carolina Hospitals - Neurology Clinic, Chapel Hill

Hospital Clínico San Carlos, Madrid

Centre Hospitalier Universitaire de Toulouse, Toulouse

Istanbul Üniversitesi - Istanbul Tip Fakültesi, Istanbul

China Medical University Hospital, Taichung

Indiana University Health University Hospital, Indianapolis

Mayo Clinic, Scottsdale

Oregon Health and Science University, Portland

University of Washington Medical Center, Seattle

Boston University School of Medicine, Boston

Hospital Italiano de Buenos Aires, Buenos Aires

Instituto Fleni, Buenos Aires

Hospital Universitario Clementino Fraga Filho, Botafogo

Universidade Estadual de Campinas, Campinas

Instituto de Neurologia de Curitiba, Curitiba

Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto, São Paulo

Vancouver General Hospital, Vancouver

Toronto General Hospital, Toronto

Centro Hospitalar Universitário Lisboa Norte - Hospital De Santa Maria, Lisbon

Centro Hospitalar Universitário do Porto - Hospital Geral de Santo Antonio, Porto

Hospital Son Llàtzer, Palma de Mallorca

Norrlands Universitetssjukhus, Umeå